Smart Patients Get Smart Care™

The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients

Dr. Andres Chang on the Watch and Wait Approach for CLL

In science and medicine, information is constantly changing and may become out-of-date as new data emerge. All articles and interviews are informational only, should never be considered medical advice, and should never be acted on without review with your health care team.

Watch and wait, also called active surveillance, is a common approach in chronic lymphocytic leukemia (CLL), where individuals are first monitored by their healthcare provider when diagnosed. CLL expert Dr. Andres Chang explains the logic behind this approach in a short video with WebMD. Visit CLL Society’s watch and wait page for more information.

Dr. Andres Chang was the recipient of CLL Society’s 2023 Young Investigator Award. Dr. Chang’s research is focused on understanding the immune response in individuals with CLL / SLL.